Daniel D. Burton - May 18, 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
May 18, 2022
Transactions value $
$971,870
Form type
4
Date filed
5/24/2022, 04:46 PM
Previous filing
Mar 3, 2022
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $200K +18.5K +5.14% $10.80 379K May 18, 2022 Direct
transaction HCAT Common Stock Options Exercise $772K +71.5K +18.86% $10.80 451K May 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -18.5K -100% $0.00* 0 May 18, 2022 Common Stock 18.5K $10.80 Direct F1
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -71.5K -46.96% $0.00 80.7K May 18, 2022 Common Stock 71.5K $10.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the 27,777 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.
F2 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.